Jau vair\u0101kus gadus p\u0113c k\u0101rtas par pa\u0161u eksportsp\u0113j\u012bg\u0101ko un intelektu\u0101l\u0101ko Latvijas produktu atz\u012bstams Mildron\u0101ts – prepar\u0101ts, kur\u0161 paredz\u0113ts sirds un asinsvadu slim\u012bbu \u0101rst\u0113\u0161anai. \u0160is prepar\u0101ts ir ieguvis popularit\u0101ti un \u0101rstu uztic\u012bbu Krievij\u0101, Ukrain\u0101, Baltkrievij\u0101, Kazahstan\u0101 un cit\u0101s NVS valst\u012bs. Viens no Mildron\u0101ta izgudrot\u0101jiem, Latvijas Organisk\u0101s Sint\u0113zes Instit\u016bta direktors, akad\u0113mi\u0137is, profesors Ivars Kalvi\u0146\u0161 st\u0101sta par tikpat unik\u0101lu \u0161\u012b prepar\u0101ta izveidi un iedarb\u012bbu.<\/p>\n\n\n\n
L\u016bdzu, past\u0101stiet, k\u0101 Latvijas zin\u0101tniekiem izdev\u0101s rad\u012bt tik unik\u0101lu prepar\u0101tu?<\/strong><\/p>\n\n\n\n \u2013 Mildron\u0101ta izveides v\u0113stures s\u0101kums dat\u0113jams ar septi\u0146desmito gadu vidu, kad man tika uzdots izdom\u0101t, k\u0101 milit\u0101ras izcelsmes izejvielas var p\u0101rveidot par sadz\u012bvei paredz\u0113tu produktu. M\u0113s izl\u0113m\u0101m, ka no t\u0101 var sintez\u0113t virkni aminosk\u0101bju, taj\u0101 skait\u0101 ar\u012b nezin\u0101m\u0101s, un turpm\u0101k izmantot \u0161os savienojumus jaunu prepar\u0101tu izveidei lauksaimniec\u012bbas vajadz\u012bb\u0101m \u2013 k\u0101 dz\u012bvnieku un augu att\u012bst\u012bbas regul\u0113t\u0101jus. Virtu\u0101li konstru\u0113jot m\u0113r\u0137a molekulas, m\u0113s non\u0101c\u0101m pie sl\u0113dziena, ka dab\u0101 jau ir viens savienojums, kur\u0161 p\u0113c savas strukt\u016bras \u013coti atg\u0101dina no jauna izveidojam\u0101s molekulas \u2013 atlika tikai aizst\u0101t vienu oglek\u013ca atomu ar sl\u0101pek\u013ca atomu. \u0160\u0101d\u0101 gad\u012bjum\u0101 b\u016btu izveidojies dabisk\u0101s aminosk\u0101bes beta\u012bna hidraz\u012bna analogs, tom\u0113r iepriek\u0161 nebija zin\u0101ma t\u0101da savienojuma klase. Topo\u0161\u0101 prepar\u0101ta dabisko prototipu m\u0113s nosauc\u0101m par gamma butirobeta\u012bna (GBB) strukt\u016branalogu un noteic\u0101m, ka organism\u0101 \u0161\u012b viela p\u0101rv\u0113r\u0161as par vitam\u012bnu BT \u2013 t\u0101 saucamo aug\u0161anas vitam\u012bnu. Tikai viena atoma aizst\u0101\u0161ana \u0161aj\u0101 molekul\u0101 rezult\u0101t\u0101 sniedza jaunu, organism\u0101 daudz notur\u012bg\u0101ku vielu, kura izr\u0101d\u012bj\u0101s pat maz\u0101k toksiska nek\u0101 cukurs vai v\u0101r\u0101mais s\u0101ls. Vispirms \u0161\u012b savienojuma ietekme tika p\u0101rbaud\u012bta laboratorij\u0101, p\u0113c tam ar\u012b augiem un dz\u012bvniekiem, un rezult\u0101t\u0101 rad\u0101s veterin\u0101rais prepar\u0101ts kvater\u012bns. Hum\u0101naj\u0101 medic\u012bn\u0101 \u0161o vielu lieto ar \u013coti augstu att\u012br\u012b\u0161anas pak\u0101pi un k\u0101 \u0101rstniec\u012bbas l\u012bdzeklis t\u0101 ir zin\u0101ma ar nosaukumu \u041cildron\u0101ts.<\/p>\n\n\n\n Kad Mildron\u0101tu s\u0101ka lietot medic\u012bn\u0101?<\/strong><\/p>\n\n\n\n \u2013 Pirmoreiz Mildron\u0101tu tika at\u013cauts izmantot medic\u012bn\u0101 1984.gad\u0101. P\u0113c jaun\u0101s molekulas farmakolo\u0123isk\u0101s aktivit\u0101tes r\u016bp\u012bgiem un pla\u0161iem p\u0113t\u012bjumiem m\u0113s p\u0101rliecin\u0101j\u0101mies par to, ka t\u0101 sp\u0113j optimiz\u0113t organisma sk\u0101bek\u013ca izmanto\u0161anu ener\u0123ijas ra\u017eo\u0161anai uz vielmai\u0146as korekcijas r\u0113\u0137ina organism\u0101. Rezult\u0101t\u0101 prepar\u0101tu var izmantot to slim\u012bbu \u0101rst\u0113\u0161anai, kuras saist\u012btas ar asinsrites nepietiekam\u012bbu un sk\u0101bek\u013ca pieg\u0101di audiem un org\u0101niem. Pirmk\u0101rt, pie \u0161\u012bm slim\u012bb\u0101m pieskait\u0101ma sirds nepietiekam\u012bba, stenokardija, ateroskleroze, trombu veido\u0161an\u0101s, miokarda infarkts, mijklibo\u0161ana, u.c.<\/p>\n\n\n\n S\u0101kum\u0101 \u0101rsti nesp\u0113ja aptvert tik pla\u0161u Mildron\u0101ta lieto\u0161anai rakstur\u012bgo simptomu un t\u0101 pielieto\u0161anas jomu, jo \u0161\u012b prepar\u0101ta \u012bpa\u0161\u012bbas nav rakstur\u012bgas cit\u0101m z\u0101l\u0113m. Tom\u0113r bija j\u0101\u0146em v\u0113r\u0101 ar\u012b tas, ka Mildron\u0101ts paties\u012bb\u0101 organism\u0101 kori\u0123\u0113 vielmai\u0146u, kas saist\u012bta ar ener\u0123ijas ra\u017eo\u0161anu un t\u0101d\u0101 veid\u0101 veicina \u0161\u016bnu adapt\u0101ciju i\u0161\u0113mijas gad\u012bjum\u0101. Turpm\u0101k pla\u0161a m\u0113roga kl\u012bniskie p\u0113t\u012bjumi apstiprin\u0101ja, ka, pateicoties t\u0101 unik\u0101lajam iedarb\u012bbas meh\u0101nismam, Mildron\u0101tu tie\u0161\u0101m var veiksm\u012bgi lietot to slim\u012bbu \u0101rst\u0113\u0161anai, kuras saist\u012btas ar asinsrites trauc\u0113jumiem konkr\u0113t\u0101 cilv\u0113ka org\u0101n\u0101. Tagad ir noteikts fakts, ka Mildron\u0101ts pal\u012bdz gan organismam kopum\u0101, gan audu un org\u0101nu \u0161\u016bn\u0101m tie\u0161i nov\u0113rst sk\u0101bek\u013ca nepietiekam\u012bbas kait\u012bgo iedarb\u012bbu, veicinot \u0161\u016bnu izdz\u012bvo\u0161anu un to darba sp\u0113ju saglab\u0101\u0161anos. Tie\u0161i t\u0101p\u0113c PSRS laikos pirmk\u0101rt par \u0161o prepar\u0101tu s\u0101ka interes\u0113ties milit\u0101rpersonas \u2013 Mildron\u0101ts bija izrakst\u012bts lidot\u0101jiem, zem\u016bdens laivu ekip\u0101\u017eas locek\u013ciem, k\u0101 ar\u012b karav\u012briem, kuriem bija j\u0101c\u012bn\u0101s augstu kalnu teritorij\u0101.<\/p>\n\n\n\n Ar ko Mildron\u0101ts ir unik\u0101ls?<\/strong><\/p>\n\n\n\n \u2013 Mildron\u0101ts \u2013 t\u0101s ir z\u0101les, ar kuru pal\u012bdz\u012bbu var regul\u0113t reakciju uz stresu un nov\u0113rst t\u0101 negat\u012bvo seku ietekmi uz organismu. K\u0101p\u0113c tas ir tik svar\u012bgi? Neliels un regul\u0101rs stress stimul\u0113 cilv\u0113ka adapt\u0113\u0161an\u0101s sp\u0113jas, t. i. piel\u0101go\u0161anos apk\u0101rt\u0113j\u0101s vides nelabv\u0113l\u012bgiem apst\u0101k\u013ciem. T\u0101 ir t\u0101 saucam\u0101 tren\u0113jo\u0161\u0101 slodze. Ja stresa intensit\u0101te ir p\u0101r\u0101k liela, vai ar\u012b, ja stress atk\u0101rtojas p\u0101r\u0101k bie\u017ei, organisma adapt\u012bv\u0101s sist\u0113mas nesp\u0113j nodro\u0161in\u0101t t\u0101du atbildes reakciju, kura nekait\u0113tu pa\u0161am cilv\u0113kam. Zin\u0101ms, ka 20-25% iedz\u012bvot\u0101ju pirm\u0101 sirdsl\u0113kme var beigties ar p\u0113k\u0161\u0146u n\u0101vi. Bez tam noskaidroj\u0101s, asas sirdsl\u0113kmes gad\u012bjum\u0101 cilv\u0113ks iet boj\u0101\u2026 no bail\u0113m. Rezult\u0101t\u0101, slimnieka organisma p\u0101rm\u0113r\u012bg\u0101 reakcija uz as\u0101m s\u0101p\u0113m, kuru laik\u0101 notiek ar\u012b p\u0101r\u0101k liela adrenal\u012bna daudzuma iepl\u016bde asin\u012bs, beidzas skumji. \u0160\u012b fenomena izskaidrojumu ir j\u0101mekl\u0113 stresa rad\u012btajos ener\u0123ijas ra\u017eo\u0161anas trauc\u0113jumos. Lai \u0123ener\u0113tu ener\u0123iju, kura \u013cautu likvid\u0113t stresa sekas, organisms savas tauku rezerves p\u0101rv\u0113r\u0161 par sadeg\u0161anai paredz\u0113t\u0101m br\u012bv\u0101m tauksk\u0101b\u0113m, kuru koncentr\u0101cija asin\u012bs strauji paaugstin\u0101s. Tom\u0113r to izmanto\u0161anai nepiecie\u0161ams milz\u012bgs daudzums sk\u0101bek\u013ca, bet slimnieka sird\u012b sk\u0101bek\u013ca daudzums nav pietiekams. \u0160\u012b iemesla d\u0113\u013c miokard\u0101 uzkr\u0101jas nesadegu\u0161u tauksk\u0101bju aktiv\u0113t\u0101s formas, kuras \u0161\u016bn\u0101m ne\u013cauj izmantot pat to nelielo ener\u0123ijas daudzumu, kuru sk\u0101bek\u013ca bada apst\u0101k\u013cos sirds \u0161\u016bn\u0101m tom\u0113r izdodas izstr\u0101d\u0101t.<\/p>\n\n\n\n Pie tam adrenal\u012bns, k\u0101 zin\u0101ms, sa\u0161aurina asinsvadus, ar to v\u0113l vair\u0101k ierobe\u017eojot asins pieg\u0101di un ar\u012b sk\u0101bek\u013ca pieg\u0101di slimnieka org\u0101niem un audiem \u2013 \u012bpa\u0161i sirdij un smadzen\u0113m. Tas ir \u013coti b\u012bstami cilv\u0113kiem, kuri slimo ar aterosklerozi, jo vi\u0146iem asinsvadu platums jau t\u0101 ir samazin\u0101ts. \u0160aj\u0101 gad\u012bjum\u0101 \u0161\u016bnas vairs nesp\u0113j ra\u017eot ener\u0123iju un iet boj\u0101. Ko tad dar\u012bt un k\u0101 pal\u012bdz\u0113t slimniekam? Secin\u0101jums ir skaidrs pats par sevi \u2013 ja nav iesp\u0113jas palielin\u0101t sk\u0101bek\u013ca pieg\u0101di, palielinot apasi\u0146o\u0161anu, vien\u012bgais veids, k\u0101 pal\u012bdz\u0113t \u0161\u016bnai izdz\u012bvot ir eso\u0161o resursu izmanto\u0161anas procesa optimiz\u0101cija. Tie\u0161i to ar\u012b veic Mildron\u0101ts \u2013 pal\u012bdz optimiz\u0113t sk\u0101bek\u013ca pat\u0113ri\u0146u organism\u0101, k\u0101 rezult\u0101t\u0101 slimnieka \u0161\u016bnas var sara\u017eot nepiecie\u0161amo ener\u0123iju ar\u012b gad\u012bjum\u0101, kad organism\u0101 ir maz\u0101ks sk\u0101bek\u013ca daudzums.<\/p>\n\n\n\n K\u0101du Mildron\u0101ta lieto\u0161anas kursu J\u016bs iesak\u0101t un vai tas ir atkar\u012bgs no saslim\u0161anas?<\/strong><\/p>\n\n\n\n \u2013 Stresa apst\u0101k\u013cos un paaugstin\u0101tas fizisk\u0101s un gar\u012bg\u0101s slodzes gad\u012bjumos norm\u0101las miesas b\u016bves cilv\u0113ks var lietot prepar\u0101tu l\u012bdz vienam gramam dien\u0101 m\u0113ne\u0161a \u2013 pusotra m\u0113ne\u0161a laik\u0101. Mildron\u0101tu ieteicams lietot ar\u012b slimniekiem ar hronisk\u0101m sirds un asinsvadu slim\u012bb\u0101m l\u012bdz pusotram gramam dien\u0101. Bez tam, \u0161\u012bs pa\u0161as Mildron\u0101ta devas ir j\u0101lieto pirms oper\u0101cij\u0101m un ar\u012b atvese\u013co\u0161an\u0101s period\u0101, jo \u0161aj\u0101 laik\u0101 audiem ar\u012b ir sk\u0101bek\u013ca bads. Jebkura psiholo\u0123iska vai emocion\u0101la p\u0101rslodze ar\u012b prasa ener\u0123ijas pat\u0113ri\u0146u \u2013 smadzenes sp\u0113j pat\u0113r\u0113t l\u012bdz 40 procentiem organisma sara\u017eot\u0101s ener\u0123ijas. M\u0113dz sac\u012bt: cukurs \u2013 t\u0101 ir balt\u0101 n\u0101ve! Bet ja cilv\u0113ka smadzenes intelektu\u0101la darba laik\u0101 nesa\u0146em pietiekamu daudzumu glikozes, var izveidoties dz\u012bv\u012bbai b\u012bstama situ\u0101cija. Mildron\u0101ts pal\u012bdz \u0161\u016bn\u0101m efekt\u012bv\u0101k uzs\u016bkt un sadedzin\u0101t cukuru. T\u0101d\u0113\u013c Mildron\u0101ts ir ar\u012b ieteicams centr\u0101l\u0101s nervu sist\u0113mas darb\u012bbas normaliz\u0113\u0161anai un \u0161ajos gad\u012bjumos to parasti lieto 10-30 dienu laik\u0101 un t\u0101 deva ir apm\u0113ram viens grams dien\u0101.<\/p>\n\n\n\n \u012apa\u0161i j\u0101piebilst, ka pati liel\u0101k\u0101 Mildron\u0101ta priek\u0161roc\u012bba vairuma sirds un asinsvadu stiprino\u0161o l\u012bdzek\u013cu vid\u016b ir t\u0101da, ka tas aktiviz\u0113 g\u0113nus, kuri atbild par organisma aizsardz\u012bbu pret stresu. T\u0113laini izsakoties, Mildron\u0101ta iedarb\u012bba pal\u012bdz uzaudz\u0113t musku\u013cus. T\u0101pat k\u0101 tren\u0113tam cilv\u0113kam, kur\u0161 k\u0101du laiku saglab\u0101 labu formu ar\u012b bez papildu tren\u0113\u0161an\u0101s, slimnieka \u0161\u016bnas p\u0113c Mildron\u0101ta kursa lieto\u0161anas ar\u012b v\u0113l pietiekami ilgi un labi p\u0101rcie\u0161 i\u0161\u0113miju.<\/p>\n","protected":false},"excerpt":{"rendered":" Jau vair\u0101kus gadus p\u0113c k\u0101rtas par pa\u0161u eksportsp\u0113j\u012bg\u0101ko un intelektu\u0101l\u0101ko Latvijas produktu atz\u012bstams Mildron\u0101ts – prepar\u0101ts, kur\u0161 paredz\u0113ts sirds un asinsvadu slim\u012bbu \u0101rst\u0113\u0161anai. \u0160is prepar\u0101ts…<\/p>\n","protected":false},"author":3,"featured_media":6601,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-744","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-jaunums"],"acf":[],"_links":{"self":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/744","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/comments?post=744"}],"version-history":[{"count":0,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/744\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media\/6601"}],"wp:attachment":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media?parent=744"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/categories?post=744"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/tags?post=744"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}